The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

A slippery droplet microarray enables parallel 3D bioprinting of separated, immersed hydrogel models, cutting array ...

Cytogenetics is rapidly advancing with innovations that merge traditional chromosome analysis with automation, AI, and high-throughput genomic tools. These developments are improving speed, accuracy, ...

Global Market OverviewThe Global Non-Invasive Prenatal Testing (NIPT) Market is projected to expand at a CAGR of 16% by 2029, ...

Americas up 9%, EMEA and APAC revenues grew 165%, each excluding 2025 license and royalty revenue. Gross Margin -- 70%, up ...

OGM Can Resolve Previously Unresolved Rare Disease CasesOGM Can Serve as a Gold Standard Technique for Characterization of SVs OGM Can Complement Sequencing for Better SV Sensitivity and Genomic ...

Prophylactic administration of obinutuzumab, a B-cell-depleting antibody, reduces the incidence of corticosteroid-requiring chronic graft-vs-host disease (cGVHD) at 1 year from 35.2% to 13.3% in ...

From automation to lean process redesign, laboratories worldwide are transforming how they handle diagnostics to deliver faster, more accurate results. These changes address bottlenecks, reduce errors ...

Illumina () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smart ...